• 6 October 2011

    Abbott enrols first patient in EXCEL trial

    Abbott has enrolled its first patient in the evaluation of XIENCE PRIME/XIENCE V versus coronary artery bypass surgery for the effectiveness of left main eervascularization (EXCEL) trial.

  • 4 October 2011

    JenaValve transapical TAVI system receives CE mark approval

    JenaValve Technology, a Germany-based medical device company, has received CE mark approval for its second-generation transapical transcatheter aortic valve implantation (TAVI) system, designed to treat severe aortic valve stenosis in...


Go Top